Can the extent of heart rate reduction predict the clinical response of infantile hemangiomas to propranolol?

Abstract

Propranolol is the first-line medical treatment of complicated infantile hemangiomas (IH)¹. It was suggested that a heart rate (HR) reduction of more than 20% compared to baseline HR might be an early marker of response to propranolol². We aim to explore the relationship between the extent of HR reduction and clinical response of IH to propranolol.

This article is protected by copyright. All rights reserved.

http://ift.tt/2wPJWXA